| 750478 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
MET overexpression contributes to STAT4-PD-L1 signaling activation associated with tumor-associated, macrophages-mediated immunosuppression in primary glioblastomas |
2021-10-01 |
10.1136/jitc-2021-002451 |
Wang Qiang-Wei, Sun Li-Hua, Zhang Ying, Wang Zheng, Zhao Zheng, Wang Zhi-Liang, Wang Kuan-Yu, Li Guan-Zhang, Xu Jian-Bao, Ren Chang-Yuan, Ma Wen-Ping, Wang Hong-Jun, Li Shou-Wei, Zhu Yong-Jian, Jiang Tao, Bao Zhao-Shi |
| 750477 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Immunosuppressive metabolites in tumoral immune evasion: redundancies, clinical efforts, and pathways forward |
2021-10-01 |
10.1136/jitc-2021-003013 |
Jennings Maria Rain, Munn David, Blazeck John |
| 750476 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Correction: Blocking IL-17A enhances tumor response to anti-PD-1 immunotherapy in microsatellite stable colorectal cancer |
2021-10-01 |
10.1136/jitc-2020-001895corr1 |
|
| 750475 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Correction: Dual PD-L1 and TGF-b blockade in patients with recurrent respiratory papillomatosis |
2021-10-01 |
10.1136/jitc-2021-003113corr1 |
|
| 750474 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Correction: A systemically deliverable Vaccinia virus with increased capacity for intertumoral and intratumoral spread effectively treats pancreatic cancer |
2021-10-01 |
10.1136/jitc-2020-001624corr1 |
|
| 750473 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Immune checkpoint inhibitors in patients with pre-existing psoriasis: safety and efficacy |
2021-10-01 |
10.1136/jitc-2021-003066 |
Halle Briana Rose, Betof Warner Allison, Zaman Farzana Y, Haydon Andrew, Bhave Prachi, Dewan Anna K, Ye Fei, Irlmeier Rebecca, Mehta Paras, Kurtansky Nicholas R, Lacouture Mario E, Hassel Jessica C, Choi Jacob S, Sosman Jeffrey A, Chandra Sunandana, Otto Tracey S, Sullivan Ryan, Mooradian Meghan J, Chen Steven T, Dimitriou Florentia, Long Georgina, Carlino Matteo, Menzies Alexander, Johnson Douglas B, Rotemberg Veronica M |
| 750472 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Correction: Tisagenlecleucel infusion in patients with relapsed/refractory ALL and concurrent serious infection |
2021-10-01 |
10.1136/jitc-2020-001225corr1 |
|
| 750471 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Correction: In situ immunogenic clearance induced by a combination of photodynamic therapy and rho-kinase inhibition sensitizes immune checkpoint blockade response to elicit systemic antitumor immunity against intraocular melanoma and its metastasis |
2021-10-01 |
10.1136/jitc-2020-001481corr1 |
|
| 750470 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Increased coexpression of PD-L1 and TIM3/TIGIT is associated with poor overall survival of patients with esophageal squamous cell carcinoma |
2021-10-01 |
10.1136/jitc-2021-002836 |
Wang Peipei, Chen Yueyun, Long Qingqin, Li Qing, Tian Jiangfang, Liu Ting, Wu Yong, Ding Zhenyu |
| 750469 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
PD-L1 quantification across tumor types using the reverse phase protein microarray: implications for precision medicine |
2021-10-01 |
10.1136/jitc-2020-002179 |
Baldelli Elisa, Hodge K Alex, Bellezza Guido, Shah Neil J, Gambara Guido, Sidoni Angelo, Mandarano Martina, Ruhunusiri Chamodya, Dunetz Bryant, Abu-Khalaf Maysa, Wulfkuhle Julia, Gallagher Rosa I, Liotta Lance, de Bono Johann, Mehra Niven, Riisnaes Ruth, Ravaggi Antonella, Odicino Franco, Sereni Maria Isabella, Blackburn Matthew, Zupa Angela, Improta Giuseppina, Demsko Perry, Crino' Lucio, Ludovini Vienna, Giaccone Giuseppe, Petricoin Emanuel F, Pierobon Mariaelena |
